the vaccines selected for study were the commercially available attenuated poliomyelitis vaccine type 2 ( sabin strain ) and the new live attenuated influenza a/england/42/72 ( h3n2 ) vaccine ( `` '' alice '' '' strain ) .
C0042211
attenuated
C0042210
vaccine